Latest Breaking News On - Cambridge innovation technologies consulting - Page 1 : comparemela.com

Led by UCD’s Prof David Brayden, Buccal-Pep aims to treat Type 2 diabetes by administering peptides such as insulin through the cheek.

United kingdomDavid braydenAdhex pharmaOrla feelyConway institute for biomolecularUniversity college dublinBerlin institute of healthNovo nordiskBiomedical researchTechnical university of denmarkProf david braydenCambridge innovation technologies consultingCatalyze innovation consultingBerlin instituteTechnical universityProf orla feely